FDA Inspection
Octapharma Plasma, Inc. - NorfolkOctapharma Plasma, Inc. - Norfolk – FDA Inspection, Dec 5, 2019
Record Details
This FDA Inspection record concerns Octapharma Plasma, Inc. - Norfolk, with an inspection on December 5, 2019, issued by the Center for Biologics Evaluation and Research, covering biologics.
- Inspection Date
- December 5, 2019
- Product Type
- Biologics
View Company Profile
ID · 9635dc2b-9194-490b-a9b2-6e1da4be41d7
Inspection Facts
No Action Indicated (NAI)
No objectionable conditions or practices were found during the inspection.
- Inspection number
- 1116508
- FDA center
- Biologics
- Project area
- Blood and Blood Products
Other FDA inspections of Octapharma Plasma, Inc. - Norfolk
5| Date | Classification | Office | Project area |
|---|---|---|---|
| December 10, 2025 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| March 14, 2017 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| November 5, 2014 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| September 11, 2012 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| August 15, 2011 | VAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
Other documents for Octapharma Plasma, Inc. - Norfolk
- FDA Inspection 1297062 - 2025-12-10
- FDA Inspection 1008325 - 2017-03-14
- FDA Inspection 903101 - 2014-11-05
- FDA Inspection 798467 - 2012-09-11
- FDA Inspection 741058 - 2011-08-15
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.